Results 261 to 270 of about 244,267 (315)

Red Blood Cell-Based Delivery Systems for the Release of Hemoglobin-Derived Peptides with In Vitro Antitumor Activities. [PDF]

Pharmaceuticals (Basel)
Bonatto CC, Joanitti GA, Silva LP.
europepmc   +1 more source

The antioxidant activity of alpha-tocopherol-bovine serum albumin complex in micellar and liposome autoxidations.

, 1985
L. R. C. Barclay, A. Bailey, Dedong Kong
openalex   +1 more source

DNA Origami‐Based CD44‐Targeted Therapy Silences Stat3 Enhances Cartilage Regeneration and Alleviates Osteoarthritis Progression

Advanced Science, EarlyView.
This study develops a cartilage‐targeted DNA origami system (OCS) that protects and delivers si‐Stat3 to chondrocytes. OCS reduces MMP13 expression, enhances extracellular matrix stability, and lowers oxidative stress while improving cell survival. In vivo, OCS decreases cartilage degradation biomarkers and promotes tissue repair factors, demonstrating
Qi Lv, Xiang Zhao, Songsong Teng, Xinmeng Jin, Ying Zhou, Yueyang Sun, Hao Pei, Zuoqin Yan, Chunhui Ma   +8 more
wiley   +1 more source

C3-Liposome Delivery of MUC1 Peptide and TLR Agonists Enhances Adaptive Immunity and Results in Sex-Based Tumor Growth Differences. [PDF]

Pharmaceutics
Soltani S, Arabi A, Mann K, Hess A, Martinson HA, Kullberg M.   +5 more
europepmc   +1 more source

Nanomedicines and the future of glioma [PDF]

, 2015
Lalatsa, Aikaterini, Moreira Leite, Diana, Pilkington, Geoffrey John   +2 more
core   +1 more source

Precision‐Guided Stealth Missiles in Biomedicine: Biological Carrier‐Mediated Nanomedicine Hitchhiking Strategy

Advanced Science, EarlyView.
Diagram illustrating the binding methods of NPs and biological barriers. The biological carrier‐mediated nanomedicine hitchhiking strategy (BCM‐NHS) utilizes two distinct techniques: the surface‐based “Backpack” method, which relies on ligand‐receptor binding, covalent conjugation, and non‐covalent binding, and the encapsulated “Trojan horse” approach,
Yuyan Zhou, Xinyue Wang, Deyu Zhang, Hanxiao Cui, Xiaorong Tian, Wei Du, Zhenghui Yang, Dongling Wan, Zhiwei Qiu, Chao Liu, Zhicheng Yang, Lizhihong Zhang, Qiusheng Yang, Xuefeng Xu, Wenhao Li, Dong Wang, Haojie Huang, Wencheng Wu   +17 more
wiley   +1 more source

Development of Inhalable Bacteriophage Liposomes Against <i>Pseudomonas aeruginosa</i>. [PDF]

Pharmaceutics
Sawant SS, Ahmed MU, Gantala NG, Chiu C, Qu L, Zhou Q.   +5 more
europepmc   +1 more source

No reduction of blood glucose in diabetic rats after oral administration of insulin liposomes prepared under acidic conditions.

, 1981
JUN KAWADA, Naoko Tanaka, Yuji Nozaki
openalex   +2 more sources

Enhanced and Durable Light‐Driven Hydrogen Evolution by Cobalt‐Based Prussian Blue Analogs in Phospholipid Bilayers

Advanced Energy and Sustainability Research, EarlyView.
Light‐driven H2 evolution catalysis is reported for oleylamine‐capped MCo Prussian blue analogs (PBAs, M = Ni, Co, Zn, Cu) within phospholipid bilayers and using a ruthenium‐based amphiphilic photosensitizer. The hydrophobic interactions between the active units bring them in close proximity facilitating catalysis.
Subrata Mandal, Akash Deshpande, Robert Leiter, Johannes Biskupek, Ute Kaiser, Andrea Pannwitz   +5 more
wiley   +1 more source

Transferrin and Borneol-Enhanced Liposomes for Targeted Rapamycin Delivery in TBI. [PDF]

Int J Nanomedicine
Cai S, Yuan Z, Chen Y, Gong M, Lai J, Yan P, Mei Z.   +6 more
europepmc   +1 more source